Fortress Biotech FBIOP
NASDAQ FBIOP
$18.27 +0.07 (+0.38%)
At close: Aug 20, 2026 · 4:00 PM EDT

Fortress Biotech, Inc. (FBIOP) EBT (2010 - 2026)

Fortress Biotech (FBIOP) posted quarterly EBT of -$6.2 million for Q4 2025, up 76.08% year-over-year from -$3.5 million in Q4 2024, and down 170.18% quarter-over-quarter from $8.9 million in Q3 2025.

Fortress Biotech, Inc. (FBIOP) EBT (2010 - 2026) Analysis & Trends

Fortress Biotech's EBT history runs 16 years deep, the most recent figure standing at -$6.2 million for Q4 2025.

  • In Q4 2025, EBT rose 76.08% year-over-year to -$6.2 million; the TTM figure through Dec 2025 stood at -$61.7 million (up 48.63% YoY), while the FY2025 annual figure was -$33.5 million, up 72.18% from the prior year.
  • EBT for Q4 2025 stood at -$6.2 million, down from $8.9 million in the prior quarter.
  • The five-year high for EBT was $8.9 million in Q3 2025, with the low at -$62.1 million in Q1 2023.
  • The 5-year median for EBT is -$38.7 million (2024), against an average of -$37.2 million.
  • The sharpest annual moves came in 2024 and 2025: EBT slumped 151.58% in 2024, then surged 133.25% in 2025.
  • Fortress Biotech's EBT stood at -$59.4 million in 2021, then grew by 4.02% to -$57.0 million in 2022, then soared by 49.81% to -$28.6 million in 2023, then gained by 9.18% to -$26.0 million in 2024, then soared by 76.08% to -$6.2 million in 2025.
  • Business Quant data shows FBIOP's EBT at -$6.2 million in Q4 2025, $8.9 million in Q3 2025, and -$39.1 million in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 922,000.00
Dec 31, 2025 -6.21 Mn
Sep 30, 2025 8.85 Mn
Jun 30, 2025 -39.06 Mn
Mar 31, 2025 -25.28 Mn
Dec 31, 2024 -25.98 Mn
Sep 30, 2024 -26.63 Mn
Jun 30, 2024 -29.18 Mn
Mar 31, 2024 -38.34 Mn
Dec 31, 2023 -28.61 Mn
Sep 30, 2023 -10.58 Mn
Jun 30, 2023 -55.82 Mn
Mar 31, 2023 -62.13 Mn
Dec 31, 2022 -57.00 Mn
Sep 30, 2022 -53.06 Mn
Jun 30, 2022 -53.93 Mn
Mar 31, 2022 -49.48 Mn
Dec 31, 2021 -59.38 Mn
Sep 30, 2021 -54.24 Mn
Jun 30, 2021 -45.47 Mn